Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| §112 only | 1 (17%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.6% | +17.0% |
| PERSONS, JENNA L | 1 | 52.8% | +65.0% |
| ZAHORIK, AMANDA MARY | 1 | 60.9% | +52.6% |
| SULLIVAN, DENNIS JOHN | 1 | 61.0% | +49.9% |
| VYAS, KEYUR ANILKUMAR | 1 | 51.5% | +63.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17720676 | OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE | POLIAKOVA-GEORGAN, EKATERINA | 191d overdue |
| 17405706 | PHOSPHONOACETATE GAPMER OLIGONUCLEOTIDES | ZAHORIK, AMANDA MARY | 89d overdue |
| 17271491 | NEOANTIGEN ENGINEERING USING SPLICE MODULATING COMPOUNDS | SULLIVAN, DENNIS JOHN | 50d overdue |
| 18340016 | OLIGONUCLEOTIDES TARGETING XBP1 | KELLY, ROBERT M | 36d overdue |
| 17264790 | OLIGONUCLEOTIDES COMPRISING A PHOSPHOROTRITHIOATE INTERNUCLEOSIDE LINKAGE | VYAS, KEYUR ANILKUMAR | 28d overdue |
| 17594154 | ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | PERSONS, JENNA L | 34d |
| Art Unit | Apps |
|---|---|
| 1637 | 3 |
| 1638 | 1 |
| 1636 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18340016 | OLIGONUCLEOTIDES TARGETING XBP1 | KELLY, ROBERT M | 1638 | §112 | Non-Final OA | 36d overdue | Pending | Jun 22, 2023 |
| 17720676 | OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Other | Non-Final OA | 191d overdue | Pending | Apr 14, 2022 |
| 17594154 | ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | PERSONS, JENNA L | 1637 | §103 | Non-Final OA | 34d | Pending | Oct 04, 2021 |
| 17405706 | PHOSPHONOACETATE GAPMER OLIGONUCLEOTIDES | ZAHORIK, AMANDA MARY | 1636 | §103 | Final Rejection | 89d overdue | Pending | Aug 18, 2021 |
| 17271491 | NEOANTIGEN ENGINEERING USING SPLICE MODULATING COMPOUNDS | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | 50d overdue | Pending | Feb 25, 2021 |
| 17264790 | OLIGONUCLEOTIDES COMPRISING A PHOSPHOROTRITHIOATE INTERNUCLEOSIDE LINKAGE | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Final Rejection | 28d overdue | Pending | Jan 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial